X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercepharma.com/pharma/end-beginning-lilly-execs-eye-top-spot-burgeoning-alzheimers-market-after-kisunlas-fda
https://www.prnewswire.com/news-releases/eisai-to-begin-enrolling-study-in-patients-with-narcolepsy-302190859.html
https://www.biospectrumasia.com/news/25/24514/japans-eisai-terminates-adc-manufacturing-pact-with-bms.html
https://www.reuters.com/business/healthcare-pharmaceuticals/japans-eisai-developing-dementia-drug-us-market-nikkei-reports-2024-06-30/
https://www.fiercebiotech.com/biotech/ensho-emerges-inflammatory-disease-portfolio-eisais-ea-pharma-stacked-leadership-team
https://www.prnewswire.com/news-releases/new-post-hoc-analysis-from-phase-3-reflect-trial-presented-at-esmo-gi-2024-explores-efficacy-outcomes-with-lenvima-lenvatinib-based-on-depth-of-tumor-response-in-unresectable-hepatocellular-carcinoma-302184539.html
https://www.prnewswire.com/news-releases/new-efficacy-data-for-non-clear-cell-renal-cell-carcinoma-from-keynote-b61-added-to-lenvima-lenvatinib-us-label-supporting-keytruda--lenvima-indication-for-the-first-line-treatment-of-adult-patients-with-advanced-rcc-302185116.html
https://www.fiercepharma.com/pharma/fda-accepts-eisais-subcutaneous-leqembi-filing-sets-january-25-decision-date
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-advisers-review-eli-lilly-alzheimers-drug-2024-06-10/
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-panel-vote-data-risk-profile-lilly-alzheimers-drug-2024-06-06/
Market Place
Share 
